文献速递中医内科中药与中成药合理使用

夏桑菊的植物化学、药理学与质量控制研究综述

Phytochemistry, Pharmacology and Quality Control of Xiasangju: A Traditional Chinese Medicine Formula.
PubMed 文献 · Front Pharmacol · 2022-06-23

夏桑菊(XSJ)在中国广泛用于退热和流感治疗,但近十年研究进展缺乏系统总结。本综述汇总其提取工艺、植物化学、药理活性与质量控制研究,指出复方药理机制多不明确,夏枯草肝毒性未被充分考虑,且缺乏系统临床试验,需进一步研究活性成分、机制及肝保护与肝毒性剂量范围以提高安全性。

要点

  • 夏桑菊广泛用于退热和流感,但复方药理机制多不明确。
  • 活性成分以三萜类、酚酸类和黄酮类为特征,但夏枯草肝毒性未被充分考虑。
  • 缺乏系统临床试验,需研究活性成分与机制并明确肝保护与肝毒性剂量范围。

核心结论

  • 夏桑菊有广泛历史实践经验,但系统临床试验仍缺乏。
  • 复方许多药理机制不明确,需研究活性成分并明确机制以拓展应用。
  • 需进一步研究夏枯草肝保护活性与肝毒性之间的剂量范围以提高临床安全性。

研究设计与样本

  • 综述类文章,汇总夏桑菊提取工艺、植物化学、药理活性与质量控制研究进展。

主要发现

  • 当前研究主要集中于单味药及活性成分的质量控制与药理作用。
  • 活性成分开发体现三萜类、酚酸类和黄酮类的活性特征。
  • 夏枯草(Prunella vulgaris L.)的肝毒性尚未被考虑。

临床怎么用

  • 临床应用夏桑菊时应关注夏枯草肝毒性风险,并重视其安全性研究。

局限性

  • 复方许多药理机制不明确。
  • 系统临床试验仍缺乏。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

As a traditional Chinese herbal formula, Xiasangju (XSJ) is widely used in China for antipyresis and influenza treatment. However, XSJ still fails to have a comprehensive summary of the research progress in the last decade. This review summarizes the advanced research on the extraction process, phytochemistry, pharmacological activity, and quality control of XSJ. Current research mainly focuses on quality control and the pharmacological effects of single herbs and active ingredients, but many pharmacological mechanisms of the formula are unclear. The development of active ingredients reflects the active characteristics of triterpenes, phenolic acids and flavonoids, but the hepatotoxicity of Prunella vulgaris L. has not been taken into account. XSJ has extensive historical practical experiences, while systematic clinical trials remain lacking. Therefore, it is necessary to study the active ingredients and define the mechanisms of XSJ to develop multiple applications, and further studies on the dose range between its hepatoprotective activity and hepatotoxicity are necessary to improve the safety of the clinical application. In this review, the current problems are discussed to facilitate the reference basis for the subsequent research on the development of XSJ and future application directions.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Wu S, Luo H, Zhong Z, et al. Phytochemistry, Pharmacology and Quality Control of Xiasangju: A Traditional Chinese Medicine Formula. Front Pharmacol. 2022. PMID: 35814215. doi:10.3389/fphar.2022.930813

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。